Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

3,621 total articles

Prologis Director Sells Small Stake as Analysts Diverge on Valuation

Prologis Director Sells Small Stake as Analysts Diverge on Valuation

Prologis director Sarah A. Slusser sold 111 shares of the REIT's common stock across transactions between July 10, 2025 and January 28, 2026, generating about $12,631. The trades occurred at prices between $108.58 and $127.57. Slusser had previously purchased 13 shares on May 14, 2025 at $107.34 and now directly holds 11 Prologis shares. The compan…

Kratos Director Sells $1.33M in Stock; Company Activity Includes Major Contracts and a $1.17B Offering

Kratos Director Sells $1.33M in Stock; Company Activity Includes Major Contracts and a $1.17B Offering

Kratos Defense & Security Solutions director Scott I. Anderson sold 15,000 shares on March 16, 2026, netting $1.33 million in five transactions executed under a 10b5-1 plan adopted September 10, 2025. The sales come amid a near 198% year-over-year share price rise, recent defense contracts and partnerships, and a $1.17 billion equity offering that …

FormFactor CEO Disposes of $973k in Stock as Company Posts Q4 Beat

FormFactor CEO Disposes of $973k in Stock as Company Posts Q4 Beat

FormFactor Inc CEO Mike Slessor sold 10,227 shares of the company's common stock on March 18, 2026, under a Rule 10b5-1 plan, realizing $973,076. The transactions were executed in three tranches at prices between $93.63 and $95.87. The sale follows the company's fourth-quarter 2025 results, which beat consensus on both EPS and revenue, while the st…

Limbach CFO Executes $778,550 10b5-1 Stock Sale

Limbach CFO Executes $778,550 10b5-1 Stock Sale

Limbach Holdings CFO Jayme L. Brooks sold 10,310 shares on March 17, 2026 under a pre-arranged 10b5-1 plan, generating $778,550. The sale comes as the stock trades well below its 52-week high and after a quarter that beat EPS estimates but missed revenue targets. Analysts have kept bullish price targets, citing stronger-than-expected margins and re…

Global Partners COO Disposes $740K in Units Across Three Days

Global Partners COO Disposes $740K in Units Across Three Days

Global Partners LP Chief Operating Officer Mark Romaine sold 15,611 common units of the partnership between March 16 and March 18, 2026, realizing approximately $740,240. The sales occurred in three tranches at weighted average prices between $47.00 and $47.76. Following the transactions Romaine holds 146,874 units. The stock trades near $47.89, wh…

Indie Semiconductor Executive Sells Class A Shares as Company Raises Capital and Secures Auto Partnership

Indie Semiconductor Executive Sells Class A Shares as Company Raises Capital and Secures Auto Partnership

Indie Semiconductor President Aoki Ichiro sold 100,000 shares of Class A common stock on March 16 and 17, 2026, collecting roughly $256,400. The transactions were carried out under a Rule 10b5-1 trading plan and coincided with a company announcement of a $150 million convertible note private placement and a technology deal with Mahindra & Mahin…

Cytokinetics CEO Sells $2.27 Million in Stock to Cover RSU Taxes

Cytokinetics CEO Sells $2.27 Million in Stock to Cover RSU Taxes

Cytokinetics President and CEO Robert I. Blum sold 36,601 shares of common stock on March 17, 2026, in two separate transactions at $62.15 per share, generating $2,274,751 in proceeds to satisfy tax-withholding obligations tied to vested restricted stock units. Multiple analysts have recently adjusted price targets higher and commented on clinical …

Ciena CEO Executes $1.06M Sale as Shares Near Yearly High

Ciena CEO Executes $1.06M Sale as Shares Near Yearly High

Gary B Smith, Ciena Corp's president and chief executive officer, sold 2,952 shares on March 16, 2026, for roughly $1.06 million under a Rule 10b5-1 trading plan. The sale came as the stock traded above the reported 52-week high and follows a robust quarter that lifted fiscal 2026 revenue guidance by 4 percentage points and attracted multiple analy…

Luxor Capital Disposes of 8,506 Meridian Holdings Shares for $71,098 as Company Advances Debt Reduction and Restructuring

Luxor Capital Disposes of 8,506 Meridian Holdings Shares for $71,098 as Company Advances Debt Reduction and Restructuring

Luxor Capital LLC, identified as a filing group holding more than 10% of Meridian Holdings Inc./NV (NASDAQ: MRDN), and its Managing Member Anthony Brian Goodman sold a total of 8,506 shares of Meridian common stock between March 11 and March 16, 2026, receiving aggregate proceeds of $71,098. The transactions took place in multiple tranches at vario…